Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
Cash Flow Under Pressure
Modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-7.64M
↑ 12% above average
Average (9y)
$-8.70M
Historical baseline
Range
High:$-4.19M
Low:$-12.09M
CAGR
+5.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-7.64M | +9.5% |
| 2023 | $-8.44M | +21.9% |
| 2022 | $-10.81M | -9.5% |
| 2021 | $-9.87M | +18.4% |
| 2020 | $-12.09M | -11.6% |
| 2019 | $-10.84M | -158.8% |
| 2018 | $-4.19M | +56.1% |
| 2017 | $-9.53M | -6.6% |
| 2016 | $-8.94M | -90.3% |
| 2015 | $-4.70M | - |